BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
suven life sciences ltd stock

SUVEN LIFE SCIENCES LTD Share Price

148.52 -9.97 (-6.29%)
Dec 12 2024 03:30 PM Healthcare NSE: SUVEN

SUVEN LIFE SCIENCES LTD Share Price Update

As of the latest trading session, SUVEN LIFE SCIENCES LTD share price is currently at 148.52, which is down by -9.97 from its previous closing. Today, the stock has fluctuated between 147.35 and 160.25. Over the past year, SUVEN LIFE SCIENCES LTD has achieved a return of 91.65 %. In the last month alone, the return has been 26.76 %. Read More...

SUVEN LIFE SCIENCES LTD Performance

Day Range

Low147.35 High160.25
148.52

52 Week Range

Low 74.50 High 169.30
148.52

SUVEN LIFE SCIENCES LTD Share Price

11233

530239

SUVEN

img img img img
No Data Available

Open Price

160.25

Prev. Close

158.50

Volume (Shares)

600204.00

Total traded value

891.42

Upper Circuit

190.20

Lower Circuit

126.80

Note: The current prices & values are delayed, Login to your account for live updates.

SUVEN LIFE SCIENCES LTD Fundamentals


(Standalone)

Market Cap (Cr) 3238.83
PE Ratio (TTM) -121.84
Book Value / Share 37.92
Beta 0.95
ROE -2.36%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -11.07

SUVEN LIFE SCIENCES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 11.69
Operating Expense 49.29
Net Profit -8.01
Net Profit Margin (%) -68.52
Earnings Per Share (EPS) -0.37
EBITDA -2.34
Effective Tax Rate (%) 11.09
Particulars MAR 2023 (Values in Cr)
Revenue 13.54
Operating Expense 48.12
Net Profit -20.13
Net Profit Margin (%) -148.67
Earnings Per Share (EPS) -1.13
EBITDA -13.30
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 11.84
Operating Expense 53.41
Net Profit -36.25
Net Profit Margin (%) -306.16
Earnings Per Share (EPS) -2.69
EBITDA -31.33
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 13.48
Operating Expense 49.19
Net Profit -22.63
Net Profit Margin (%) -167.87
Earnings Per Share (EPS) -1.78
EBITDA -22.78
Effective Tax Rate (%) 19.03
Particulars MAR 2020 (Values in Cr)
Revenue 14.41
Operating Expense 54.39
Net Profit -13.75
Net Profit Margin (%) -95.41
Earnings Per Share (EPS) -1.08
EBITDA -21.28
Effective Tax Rate (%) 46.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 12.38
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -951.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -822.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 6.61
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.04
EBITDA Margin -987.58
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.58
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.04
EBITDA Margin -535.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 11.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin -705.62
Particulars MAR 2024 (Values in Cr)
Book Value / Share 38.77
ROE % -2.36
ROCE % -2.44
Total Debt to Total Equity 0.00
EBITDA Margin -122.16
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.14
ROE % -4.20
ROCE % -4.11
Total Debt to Total Equity 0.00
EBITDA Margin -154.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 32.74
ROE % -9.17
ROCE % -8.90
Total Debt to Total Equity 0.01
EBITDA Margin -297.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 28.66
ROE % -5.73
ROCE % -6.73
Total Debt to Total Equity 0.01
EBITDA Margin -168.40
Particulars MAR 2020 (Values in Cr)
Book Value / Share 30.46
ROE % -3.48
ROCE % -6.33
Total Debt to Total Equity 0.01
EBITDA Margin -147.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 163.97
Total Assets 284.90
Total Liabilities 284.90
Total Equity 270.04
Share Outstanding 218073717
Price to Book Ratio 2.57
Return on Assets (%) -36.88
Return on Capital (%) -38.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 184.28
Total Assets 388.91
Total Liabilities 388.91
Total Equity 375.31
Share Outstanding 218073717
Price to Book Ratio 1.24
Return on Assets (%) -30.41
Return on Capital (%) -31.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.52
Total Assets 108.03
Total Liabilities 108.03
Total Equity 96.14
Share Outstanding 145382478
Price to Book Ratio 2.83
Return on Assets (%) -112.92
Return on Capital (%) -126.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 46.64
Total Assets 128.41
Total Liabilities 128.41
Total Equity 108.00
Share Outstanding 127282478
Price to Book Ratio 2.46
Return on Assets (%) -56.18
Return on Capital (%) -65.99
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 15.09
Total Assets 181.93
Total Liabilities 181.93
Total Equity 143.34
Share Outstanding 127282478
Price to Book Ratio 0.70
Return on Assets (%) -51.78
Return on Capital (%) -65.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 153.44
Total Assets 851.48
Total Liabilities 851.48
Total Equity 845.37
Share Outstanding 218073717
Price to Book Ratio 2.57
Return on Assets (%) -0.94
Return on Capital (%) -0.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 173.95
Total Assets 860.44
Total Liabilities 860.44
Total Equity 853.44
Share Outstanding 218073717
Price to Book Ratio 1.24
Return on Assets (%) -2.33
Return on Capital (%) -2.36
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.14
Total Assets 486.35
Total Liabilities 486.35
Total Equity 475.97
Share Outstanding 145382478
Price to Book Ratio 2.83
Return on Assets (%) -7.45
Return on Capital (%) -7.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 38.59
Total Assets 415.38
Total Liabilities 415.38
Total Equity 401.65
Share Outstanding 127282478
Price to Book Ratio 2.46
Return on Assets (%) -5.44
Return on Capital (%) -5.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 409.75
Total Liabilities 409.75
Total Equity 387.67
Share Outstanding 127282478
Price to Book Ratio 0.70
Return on Assets (%) -3.35
Return on Capital (%) -3.54
Particulars MAR 2024 (Values in Cr)
Net Income -106.07
Cash from Operations -121.64
Cash from Investing 94.43
Cash from Financing -1.05
Net change in Cash -22.08
Free Cash Flow -121.64
Particulars MAR 2023 (Values in Cr)
Net Income -118.26
Cash from Operations -114.87
Cash from Investing -247.81
Cash from Financing 395.53
Net change in Cash 31.74
Free Cash Flow -111.98
Particulars MAR 2022 (Values in Cr)
Net Income -121.99
Cash from Operations -127.01
Cash from Investing -22.22
Cash from Financing 145.69
Net change in Cash -4.07
Free Cash Flow -107.24
Particulars MAR 2021 (Values in Cr)
Net Income -77.47
Cash from Operations -94.87
Cash from Investing 55.84
Cash from Financing 34.85
Net change in Cash -5.32
Free Cash Flow -88.57
Particulars MAR 2020 (Values in Cr)
Net Income -106.40
Cash from Operations -131.79
Cash from Investing 146.21
Cash from Financing 2.80
Net change in Cash 14.44
Free Cash Flow -129.40
Particulars MAR 2024 (Values in Cr)
Net Income -9.01
Cash from Operations -26.73
Cash from Investing -0.67
Cash from Financing -1.05
Net change in Cash -22.29
Free Cash Flow -26.73
Particulars MAR 2023 (Values in Cr)
Net Income -20.12
Cash from Operations -21.81
Cash from Investing -348.82
Cash from Financing 395.53
Net change in Cash 23.79
Free Cash Flow -18.92
Particulars MAR 2022 (Values in Cr)
Net Income -36.24
Cash from Operations -36.10
Cash from Investing -107.45
Cash from Financing 145.69
Net change in Cash 1.60
Free Cash Flow -16.33
Particulars MAR 2021 (Values in Cr)
Net Income -27.95
Cash from Operations -35.53
Cash from Investing 2.41
Cash from Financing 34.85
Net change in Cash 0.58
Free Cash Flow -29.23
Particulars MAR 2020 (Values in Cr)
Net Income -25.93
Cash from Operations -42.36
Cash from Investing 42.03
Cash from Financing 3.81
Net change in Cash 0.69
Free Cash Flow -39.98
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 89.24 14.08 105571.01 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.99 0.00 3.95 118.05 44.00 / 107.94
SHREE PACETRONIX LTD. 121.20 19.52 3.24 43.62 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.66 0.00 5.35 58.04 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 94.01 12.88 105571.01 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 54.13 0.00 -28.99 40.44 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5427.00 29.43 6.09 5937.14 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 150.80
  • 26 Days 134.50
  • 10 Days 143.40
  • 50 Days 133.40
  • 12 Days 140.80
  • 100 Days 134.40
  • 20 Days 135.70
  • 200 Days 112.60
159.95
PIVOT
First Resistance 165.73
Second Resistance 172.96
Third Resistance 178.74
First Support 152.72
Second Support 146.94
Third Support 139.71
RSI 75.05
MACD 6.29
Commodity Channel Index (CCI) 194.29
ADX 37.67
Williams % R -17.17

Over 1 Month

down

26.76

Over 3 Months

down

2.74

Over 6 Months

down

56.94

Over 1 Year

down

91.65

Over 3 Years

down

22.95

Over 5 Years

down

66.01

SUVEN LIFE SCIENCES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SUVEN LIFE SCIENCES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
28.34
Promoter Holdings
70.26
FII
0.33
DII
1.05
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Jasti Property And Equity Holdings Private Limited (initscapacityassoletrusteeofjastifamilytrust) Shareholding of Promoter and Promoter Group 1.516975E8 69.56
Rambabu Chirumamilla Public Shareholding 3000000.0 1.38
Quant Mutual Fund - Quant Business Cycle Fund Public Shareholding 2280000.0 1.05
Sudharani Jasti Shareholding of Promoter and Promoter Group 1528535.0 0.7
Venkateswarlu Jasti Shareholding of Promoter and Promoter Group 2201.0 0.0
Sirisha Jasti Shareholding of Promoter and Promoter Group 1000.0 0.0
Kalyani Jasti Shareholding of Promoter and Promoter Group 1000.0 0.0
Madhavi Jasti Shareholding of Promoter and Promoter Group 1000.0 0.0

SUVEN LIFE SCIENCES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2019-02-14 1.5 Interim 2019-02-15 Equity shares 2018-02-06 1.5 Interim 2018-02-07 Equity shares 2017-02-08 1.0 Interim 2017-02-09 Equity shares 2016-03-14 1.0 Interim 2016-03-15 Equity shares 2016-03-14 1.0 Special 2016-03-15 Equity shares 2015-07-23 0.6 Final 2015-07-25 Equity shares 2014-07-24 0.5 Final 2014-07-26 Equity shares 2014-07-24 2.0 Special 2014-07-26 Equity shares 2013-08-01 0.3 Final 2013-08-05 Equity shares 2012-09-17 0.3 Final 2012-09-19 Equity shares 2011-08-01 0.25 Final 2011-08-03 Equity shares 2010-07-19 0.25 Final 2010-07-21 Equity shares 2009-09-14 0.25 Final 2009-09-16 Equity shares 2008-09-11 0.25 Final 2008-09-13 Equity shares 2007-09-21 0.25 Final 2007-09-25 Equity shares 2006-09-25 0.0 Final 2006-09-27 Equity shares 2005-09-05 0.0 Final 2005-09-08 Equity shares
Ex-Date Ex-Bonus Ratio
2007-04-02 2007-03-23 1:1
Ex-Date Old FV NEW FV Record Date
2007-03-23 2.0 1.0 2007-04-02 2004-01-15 10.0 2.0 2004-01-23

Learn More About Stocks

About SUVEN LIFE SCIENCES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SUVEN LIFE SCIENCES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Suven Life Sciences Ltd?

Answer Field

The share price of Suven Life Sciences Ltd for NSE is ₹ 148.52 and for BSE is ₹ 148.95.

What is the Market Cap of Suven Life Sciences Ltd?

Answer Field

The market cap of Suven Life Sciences Ltd for NSE is ₹ 32,38.83 Cr. and for BSE is ₹ 32,48.20 Cr. as of now.

What is the 52 Week High and Low of Suven Life Sciences Ltd?

Answer Field

The 52 Week High and Low of Suven Life Sciences Ltd for NSE is ₹ 169.30 and ₹ 74.50 and for BSE is ₹ 169.00 and ₹ 75.95.

How to Buy Suven Life Sciences Ltd share?

Answer Field

You can trade in Suven Life Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Suven Life Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 91.65%.

What is the Current Share Price of Suven Life Sciences Ltd?

Answer Field

Suven Life Sciences Ltd share price is for NSE ₹ 148.52 & for BSE ₹ 148.95 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Suven Life Sciences Ltd Share?

Answer Field

The market cap of Suven Life Sciences Ltd for NSE ₹ 32,38.83 & for BSE ₹ 32,48.20 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Suven Life Sciences Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Suven Life Sciences Ltd share is -121.84.

What is the PB ratio of Suven Life Sciences Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Suven Life Sciences Ltd share is 37.92.

How to Buy Suven Life Sciences Ltd Share?

Answer Field

You can trade in Suven Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Suven Life Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Suven Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Suven Life Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader